These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 19369969)
1. Progress and prospects: biological properties and technological advances of herpes simplex virus type 1-based amplicon vectors. Epstein AL Gene Ther; 2009 Jun; 16(6):709-15. PubMed ID: 19369969 [TBL] [Abstract][Full Text] [Related]
2. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome. Saeki Y; Fraefel C; Ichikawa T; Breakefield XO; Chiocca EA Mol Ther; 2001 Apr; 3(4):591-601. PubMed ID: 11319922 [TBL] [Abstract][Full Text] [Related]
3. Increased transcomplementation properties of plasmids carrying HSV-1 origin of replication and packaging signals. Berthomme H; Fournel S; Epstein AL Virology; 1996 Feb; 216(2):437-43. PubMed ID: 8607275 [TBL] [Abstract][Full Text] [Related]
4. Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas. Pechan PA; Herrlinger U; Aghi M; Jacobs A; Breakefield XO J Gene Med; 1999; 1(3):176-85. PubMed ID: 10738566 [TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus type 1-derived recombinant and amplicon vectors. Fraefel C; Marconi P; Epstein AL Methods Mol Biol; 2011; 737():303-43. PubMed ID: 21590403 [TBL] [Abstract][Full Text] [Related]
6. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector. Oehmig A; Cortés ML; Perry KF; Sena-Esteves M; Fraefel C; Breakefield XO Gene Ther; 2007 Jul; 14(14):1078-91. PubMed ID: 17460718 [TBL] [Abstract][Full Text] [Related]
7. Targeted transgene integration into transgenic mouse fibroblasts carrying the full-length human AAVS1 locus mediated by HSV/AAV rep(+) hybrid amplicon vector. Bakowska JC; Di Maria MV; Camp SM; Wang Y; Allen PD; Breakefield XO Gene Ther; 2003 Sep; 10(19):1691-702. PubMed ID: 12923568 [TBL] [Abstract][Full Text] [Related]
12. Establishment of a novel foreign gene delivery system combining an HSV amplicon with an attenuated replication-competent virus, HSV-1 HF10. Zhang L; Daikoku T; Ohtake K; Ohtsuka J; Nawa A; Kudoh A; Iwahori S; Isomura H; Nishiyama Y; Tsurumi T J Virol Methods; 2006 Nov; 137(2):177-83. PubMed ID: 16854473 [TBL] [Abstract][Full Text] [Related]
13. Gene transfer into hepatocytes mediated by herpes simplex virus-Epstein-Barr virus hybrid amplicons. Müller L; Saydam O; Saeki Y; Heid I; Fraefel C J Virol Methods; 2005 Jan; 123(1):65-72. PubMed ID: 15582700 [TBL] [Abstract][Full Text] [Related]
14. Plasmid DNA sequences present in conventional herpes simplex virus amplicon vectors cause rapid transgene silencing by forming inactive chromatin. Suzuki M; Kasai K; Saeki Y J Virol; 2006 Apr; 80(7):3293-300. PubMed ID: 16537596 [TBL] [Abstract][Full Text] [Related]
15. Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA. Sabbioni S; Callegari E; Manservigi M; Argnani R; Corallini A; Negrini M; Manservigi R Gene Ther; 2007 Mar; 14(5):459-64. PubMed ID: 17051250 [TBL] [Abstract][Full Text] [Related]
16. Optimal purification method for Herpes-based viral vectors that confers minimal cytotoxicity for systemic route of vector administration. Sia KC; Wang GY; Ho IA; Khor HY; Miao L; Hui KM; Lam PY J Virol Methods; 2007 Feb; 139(2):166-74. PubMed ID: 17074404 [TBL] [Abstract][Full Text] [Related]